Novo Nordisk : NVO

All Novo Nordisk Articles

168 Articles

Trey Thoelcke | Nov 5, 2025 at 8:45 AM EST

Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More

In the past week or so, a biotech and an energy infrastructure giant saw some huge insider buying. These were…

Rich Duprey | Nov 3, 2025 at 10:13 AM EST

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that…

Rich Duprey | Oct 22, 2025 at 11:48 AM EDT

Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank

The U.S. stock market has delivered impressive gains for over a decade, but warning signs of a potential downturn are…

Rich Duprey | Oct 17, 2025 at 11:05 AM EDT

Is Trump Going to Kill the GLP-1 Cash Cow?

The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and diabetes treatments into massive…

Rich Duprey | Oct 1, 2025 at 10:47 AM EDT

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

Starting today, the U.S. imposed 100% tariffs on imports of branded or patented pharmaceutical products that President Trump announced last…

Omor Ibne Ehsan | Sep 17, 2025 at 10:28 AM EDT

3 Stocks Insiders Are Buying Non-Stop

Insider buying is one of the few market signals that does not hide behind algorithms or price targets. When a…

Omor Ibne Ehsan | Sep 2, 2025 at 3:45 PM EDT

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Healthcare investing has felt like walking through quicksand this year. One moment, the sector looks ready to spring forward on…

Rich Duprey | Aug 27, 2025 at 8:23 AM EDT

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway success of…

Rich Duprey | Aug 22, 2025 at 12:13 PM EDT

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) has been a trailblazer in…

Joel South | Aug 19, 2025 at 9:08 AM EDT

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

This article will be updated throughout the day, so check back often for more daily updates. It’s a pretty slow…

Joel South | Aug 18, 2025 at 9:12 AM EDT

Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks

This article will be updated throughout the day, so check back often for more daily updates. The S&P 500 closed…

Rich Duprey | Aug 6, 2025 at 11:35 AM EDT

There Is Only 1 GLP-1 Stock to Buy In 2025

Weighing the Options The introduction of Novo Nordisk’s (NYSE:NVO | NVO Price Prediction) Ozempic revolutionized the fight against obesity, shifting…

Rich Duprey | Jul 29, 2025 at 11:25 AM EDT

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) is watching its stock plummet 20% in morning trading after…

Rich Duprey | Jul 24, 2025 at 10:22 AM EDT

Is Hims & Hers the Newest Meme Stock Darling?

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high…

Rich Duprey | Jul 16, 2025 at 10:55 AM EDT

3 Ridiculously Discounted Growth Stocks to Buy Now

Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it…

1 2 3 4 5 6 … 12

Novo Nordisk : NVO

All Novo Nordisk Articles

Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank

Is Trump Going to Kill the GLP-1 Cash Cow?

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

3 Stocks Insiders Are Buying Non-Stop

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks

There Is Only 1 GLP-1 Stock to Buy In 2025

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Is Hims & Hers the Newest Meme Stock Darling?

3 Ridiculously Discounted Growth Stocks to Buy Now

If I Could Only Own 1 ETF for the Rest of 2026, It Would Be This One

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This

If I Could Only Own 1 ETF for the Rest of 2026, It Would Be This One

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

Novo Nordisk : NVO

All Novo Nordisk Articles

Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank

Is Trump Going to Kill the GLP-1 Cash Cow?

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

3 Stocks Insiders Are Buying Non-Stop

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks

There Is Only 1 GLP-1 Stock to Buy In 2025

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Is Hims & Hers the Newest Meme Stock Darling?

3 Ridiculously Discounted Growth Stocks to Buy Now

If I Could Only Own 1 ETF for the Rest of 2026, It Would Be This One

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

Featured Reads

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This